Briet Marie, Schiffrin Ernesto L
Université Paris Descartes, Faculté de Medicine, Assistance Publique des Hôpitaux de Paris, Hôpital Européen Georges Pompidou, INSERM CIC 9201, Paris, France.
J Vasc Res. 2013;50(2):89-99. doi: 10.1159/000345243. Epub 2012 Nov 21.
Aldosterone exerts direct effects on the vascular system by inducing oxidative stress, inflammation, hypertrophic remodeling, fibrosis, and endothelial dysfunction. Aldosterone exerts its effects through genomic and nongenomic pathways in a mineralocorticoid receptor (MR)-dependent or independent manner. Other aldosterone receptors such as GPR30 have been identified. A tight relation exists between the aldosterone and angiotensin II pathways, as well as with the endothelin-1 system. There is a correlation between plasma levels of aldosterone and cardiovascular risk. Recently, an increasing body of evidence has underlined the importance of aldosterone in cardiovascular complications associated with the metabolic syndrome, such as arterial remodeling and endothelial dysfunction. Blockade of MR is an increasingly used evidence-based therapy for many forms of cardiovascular disease, including hypertension, heart failure, chronic kidney disease, and diabetes mellitus.
醛固酮通过诱导氧化应激、炎症、肥厚性重塑、纤维化和内皮功能障碍对血管系统产生直接影响。醛固酮通过基因组和非基因组途径以盐皮质激素受体(MR)依赖性或非依赖性方式发挥作用。已鉴定出其他醛固酮受体,如GPR30。醛固酮与血管紧张素II途径以及内皮素-1系统之间存在密切关系。醛固酮的血浆水平与心血管风险之间存在相关性。最近,越来越多的证据强调了醛固酮在与代谢综合征相关的心血管并发症中的重要性,如动脉重塑和内皮功能障碍。MR阻断是一种越来越多地用于多种形式心血管疾病的循证治疗方法,包括高血压、心力衰竭、慢性肾脏病和糖尿病。